Shared on18 Aug 25Fair value Decreased 15%
Despite a sharp improvement in Oneview Healthcare’s net profit margin and a substantial reduction in its future P/E ratio, analysts have lowered their fair value estimate, cutting the consensus price target from A$0.419 to A$0.355. Valuation Changes Summary of Valuation Changes for Oneview Healthcare The Consensus Analyst Price Target has significantly fallen from A$0.419 to A$0.355.